Chemomab Therapeutics Ltd. (CMMB)
Market Open
15 Jun, 14:41
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 58
-0.07
-4.2424%
$
10.16M Market Cap
- P/E Ratio
- Div Yield
17,011 Volume
- Eps
$ 1.65
Previous Close Investors:
Want to track CMMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Chemomab Therapeutics Ltd. (CMMB) Statistics
Valuation metrics
Market Cap 10.16M
Enterprise value 4.25M
Trailing P/E (ttm) -1.77
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 1.23
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 63.72K
Average volume (90 days) 44.84K
Price summary
52-Week low 1.35
52-Week high 5.04
Beta -
50-Day moving average 1.69
200-Day moving average 1.8
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 26 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.63%
Return on equity -0.68%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.93
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.01
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 10.31%
Book value per share (mrq) 1.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
